Steve Schonfeld’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383K Buy
+99,537
New +$363K ﹤0.01% 1928
2026
Q1
Sell
-15,525
Closed -$105K 2480
2025
Q4
$105K Buy
+15,525
New +$109K ﹤0.01% 1814
2025
Q2
Sell
-18,600
Closed -$141K 2339
2025
Q1
$141K Buy
+18,600
New +$155K ﹤0.01% 1982
2024
Q3
Sell
-17,472
Closed -$121K 2255
2024
Q2
$121K Buy
+17,472
New +$123K ﹤0.01% 1867
2021
Q2
Sell
-22,189
Closed -$228K 2157
2021
Q1
$228K Sell
22,189
-6,379
-22% -$61.6K ﹤0.01% 1445
2020
Q4
$260K Buy
+28,568
New +$206K ﹤0.01% 1251

Other funds holding MDXG

Steve Schonfeld's MDXG Position: Q2 2026 in Review

Steve Schonfeld opened a new position in MiMedx Group (MDXG) in Q2 2026: 99,537 shares worth $383K. The stake represents ﹤0.01% of the portfolio and ranks #1928 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in MDXG as recently as Q4 2025.

Steve Schonfeld first reported a position in MDXG in Q4 2020 and has held it in 6 quarters since. 225 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Steve Schonfeld held 99,537 shares of MiMedx Group worth $383K as of Q2 2026.
  • MiMedx Group was a new Steve Schonfeld position in Q2 2026.
  • MiMedx Group made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1928 holding.
  • Steve Schonfeld first reported a position in MiMedx Group in Q4 2020 and has held it in 6 quarters since.
  • 225 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.